Staphylococcus lugdunensis strain with a modified PBP1A/1B expressing resistance to β-lactams

Eur J Clin Microbiol Infect Dis. 2012 Feb;31(2):169-72. doi: 10.1007/s10096-011-1289-8. Epub 2011 May 19.

Abstract

We describe for the first time the emergence of an mecA-negative Staphylococcus lugdunensis strain with a modified PBP1A/1B that expresses resistance to all β-lactams. A duplication of the tetrapeptide S(569)AYG, which is part of the transpeptidase domain of PBP1A/1B and closely located to the K(583)TG catalytic motif, was associated with this unusual phenotype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology*
  • Endocarditis, Bacterial / microbiology
  • Female
  • Humans
  • Microbial Sensitivity Tests
  • Models, Molecular
  • Penicillin-Binding Proteins / chemistry
  • Penicillin-Binding Proteins / genetics*
  • Peptidyl Transferases / chemistry
  • Peptidyl Transferases / genetics*
  • Staphylococcal Infections / microbiology
  • Staphylococcus lugdunensis / drug effects*
  • Staphylococcus lugdunensis / genetics
  • Staphylococcus lugdunensis / isolation & purification
  • Staphylococcus lugdunensis / metabolism
  • beta-Lactam Resistance* / genetics
  • beta-Lactams / pharmacology

Substances

  • Anti-Bacterial Agents
  • Penicillin-Binding Proteins
  • beta-Lactams
  • Peptidyl Transferases